Cephalosporin Intermediate Crystallization via Toluene Solvate
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis methods for ceftolozane, particularly the isolation using diisopropyl ether, are hazardous due to its high flammability and potential to form peroxides, and there is a need for improved reaction yields, safety, and efficiency in the synthesis of the intermediate compound (III), which is crucial for the production of ceftolozane.
Innovation Solution
A crystalline form of compound (III) is developed, specifically a toluene solvate, which is safer and more efficient, with characteristic XRPD patterns and a process involving admixing a non-crystalline form with an aromatic solvent like toluene to form a crystalline form, enhancing stability and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If diisopropyl ether is used for isolation in the synthesis of compound (III), then the compound can be isolated, but the process becomes hazardous due to high flammability and peroxide formation
Solution Approach 1:
The patent changes the physical and chemical parameters of the isolation process by replacing diisopropyl ether with toluene, a solvent with fundamentally different safety characteristics (lower flammability, no peroxide formation). This parameter substitution resolves the safety contradiction while maintaining isolation effectiveness.
Solution Approach 2:
The patent employs a crystallization process using toluene that produces a stable crystalline intermediate, eliminating the need for hazardous ether-based isolation. The process uses readily available toluene and produces a stable solid product that can be handled safely.
2Productivity
If conventional isolation methods are used, then the synthesis can proceed, but reaction yields and overall efficiency are insufficient
Solution Approach 1:
The patent utilizes phase transition from liquid to crystalline state to isolate compound (III). The crystallization process from toluene solution provides both high purity and high yield while eliminating safety hazards associated with ether-based methods. The controlled crystallization ensures efficient product recovery.
3Stability of the object's composition
If amorphous solid form is used, then the compound is obtained, but chemical stability under environmental stressors is reduced
Solution Approach 1:
The patent deliberately induces crystallization from toluene solution to produce a stable crystalline solid form of compound (III). This phase transition from amorphous to crystalline state enhances chemical stability under environmental stressors such as heat and moisture, while the controlled crystallization process ensures consistent solid form quality.
Data Source
AI summary
Described herein are crystalline forms of a compound of formula (III′), including toluene solvates of TATD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane.